期刊文献+

肾上腺区域Castleman病的外科治疗

Surgical treatment of castleman disease of adrenal gland
下载PDF
导出
摘要 目的探讨肾上腺区域Castleman病的临床表现和外科治疗。方法回顾性分析2003--2013年4例。肾上腺区域Castleman病的临床表现、治疗过程及预后,其中男性1例,女性3例,肿瘤直径4~7cm,均以肾上腺肿瘤收入院且缺乏肾上腺肿瘤的特异性临床表现。结果4例肾上腺肿瘤均行手术切除,肿瘤位于肾脏血管和下腔静脉或腹主动脉之间,和周围组织广泛粘连。术后病理报告为Castleman病,其中透明血管型3例(HV);浆细胞型1例(PC)。4例均认可为良眭疾病,术后失访1例,余3例患者现均存活,无肿瘤复发。结论Castleman病临床上较为少见,而肾上腺区的Castleman病则更为罕见。因此,对于肾上腺区域的肿瘤而又缺乏。肾上腺肿瘤特异性临床表现的患者应考虑到患Castleman病可能,手术切除肿瘤疗效可靠,但确诊需依靠术后的病理检查。 Objective To explore the clinical manifestations and surgical treatment of Castleman disease of adrenal region. Methods The clinical performance, treatment and prognosis of 4 cases of Castleman disease of the adrenal region which include 1 male and 3 females from 2003 to 2013 were reviewed retrospectively. They were admitted to the hospital due to adrenal region tumors but without the specific clinical manifestations of adrenal tumor. The diameters of tumors were 4 -7 cm. Results All 4 cases underwent surgical resection, the tumors were located between the kidney blood vessels and the inferior vena cava or abdominal aorta, and kept extensive adhesions with surrounding tissues, and were confirmed as Castleman disease by postoperative pathology experiment, which included three cases of hyaline vascular type (HV) and 1 case of plasma cell type(PC). 4 patients were recognized as benign disease, one of them was lost to follow and the other 3 patients were alive without evidence of recurrence. Conclusion Castleman disease is rarely and even more rare in the adrenal region disease. Therefore, the patient with adrenal region tumors and lack of adrenal tumor-specific clinical manifestations should be considered as Castleman disease. Surgical resection of the tumor is effective and reliable, but the diagnosis must rely on the postoperative pathological examination.
作者 周文生 李岗
出处 《中华全科医学》 2014年第3期399-400,共2页 Chinese Journal of General Practice
关键词 肾上腺区Castleman病 鉴别诊断 外科治疗 Castleman disease of the adrenal gland Differential diagnosis Surgical treatment
  • 相关文献

参考文献5

二级参考文献68

  • 1武淑兰,李竞贤,陈宏民,聂立功,王颖,许广润.Castleman病八例的临床病理学研究[J].中华内科杂志,1994,33(3):179-182. 被引量:33
  • 2刘芳,李红华,金斗,杜广清,于力.4例Castleman病临床观察及文献分析[J].中国临床医学,2007,14(2):270-272. 被引量:14
  • 3陆世丰,陆化,吴汉新,徐卫,张建富,李建勇.酷似干燥综合征起病的多中心型Castleman病1例报告并文献复习[J].中国误诊学杂志,2007,7(6):1183-1185. 被引量:2
  • 4Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care [J]. Sr J Haematol, 2005, 129( 1 ) :3-17.
  • 5Dupin N, Fisher C, Kellam P, et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, muhicentric Castleman's disease, and primary effusion lymphoma [J]. Proc Natl Acad Sci USA, 1999, 96(8) :4546- 4551.
  • 6Parravicini C, Corbellino M, Paulli M, et al. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease [J]. Am J Pathol, 1997, 151 (6): 1517-1522.
  • 7Oksenhendler E, Careelain G, Aoki Y, et al. High levels of HHV8 viral load, human interleukin-6, interleukin-10, and C reactive protein are correlate with exacerbation of multicentric Castleman disease in HIV-infected patients [ J ]. Blood, 2000, 96 (6) :2069-2073.
  • 8Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease [J]. Blood, 1995, 86(4) :1276- 1280.
  • 9Yamasaki S, Iino T, Nakamura M, et al. Detection of human herpesvirus-8 in peripheral blood mononuclear cells from adult Japanese patients with uhicentric Castleman's disease [J]. Br J Haematol, 2003, 120(3) :471-477.
  • 10Tedeschi R, Marus A, Bidoli E, et al. Human herpesvirus 8 DNA quantification in matched plasma and PBMCs samples of patients with HHV8-related lymphoproliferative diseases [J]. J Clin Virol, 2008, 43(3) :255-259.

共引文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部